GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Eloxx Pharmaceuticals ELOX · USD

Health Care · US listing · 🇺🇸 United States

Compare

13.51

+8.60%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Eloxx Pharmaceuticals

Our reporting

We have not reported on Eloxx Pharmaceuticals yet.

Next results

10 Nov 2026

Due on 10 Nov 2026. Analysts expect earnings of -0.58 a share.

Past results

Reported against what analysts expected

11 Aug 20265 May 202617 Apr 202512 Nov 202314 Aug 202315 May 2023
Earnings per share-0.66-0.88-4.95-14.41-21.56-31.68
Forecast-0.70-6.40—-1.97-1.54-2.55
Forecast—————$700,000

Key events

  1. 1 Jun 202611-to-1 reverse split
  2. 2 Dec 202240-to-1 reverse split
  3. 20 Dec 201720-to-1 reverse split
  4. 21 Oct 2013100-to-1 reverse split
  5. 23 Nov 2012Listed
  6. 25 Oct 19992-for-1 share split

Eloxx Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.